학술논문

Long-term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study
Document Type
Article
Source
In: Cancer Science. (Cancer Science, April 2024, 115(4):1296-1305)
Subject
Language
English
ISSN
13497006
13479032